Navigation Links
Global Vision Recognized for Helping Pharmaceutical Companies Achieve Complete Artwork and Copy Accuracy in their Packaging Process

MONTREAL, Oct. 22 /PRNewswire/ -- Global Vision, the leader in automated proofreading solutions for the pharmaceutical industry announced today that 15 of the top 20 pharmaceutical companies have selected Global Vision to help them reduce the risk of textual and artwork errors from occurring in their packaging process. The integration of automated proofreading technology has resulted in a reduction of quality issues and costs, along with speeding up product launches.

Debi Schimpf, Associate Director at Wyeth comments "Global Vision has helped us implement better methods for detecting errors before they become costly. They're extremely knowledgeable when it comes to securing the artwork packaging workflow. Over the last 10 years of working with Global Vision, we have realized significant benefits and financial savings."

In the pharmaceutical manufacturing environment, there are thousands of packaging components being produced in a multitude of languages each year. Keeping track of the accuracy of these materials is a complex and challenging undertaking. Global Vision's technology is becoming a standard way for companies to ensure that their products reach the shelves without labeling errors.

"These companies are turning to us because we can offer them a safer and simpler way to work. Our customers need to feel confident in their approval and change control process. We give them peace of mind, along with the added benefits of decreased approval times and significant cost savings," says President Reuben Malz.

Global Vision is committed to providing solutions to ensure that all aspects of the packaging process are accurate. Global Vision has recently integrated Braille inspection capabilities into all its solutions in compliance with the recent EMEA regulations that require Braille on labels and cartons.

All systems meet EMEA and FDA 21 CFR Part 11 requirements.

About Global Vision

Global Vision provides automated proofreading solutions that enable organizations to achieve unprecedented content integrity. Major pharmaceutical companies rely on Global Vision to reduce the risk of textual or artwork errors from occurring throughout their workflow. For over a decade, Global Vision has helped clients increase inspection accuracy, speed, productivity, and process efficiencies. More information is available at .

SOURCE Global Vision, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Video: OneTouch(R) Teams With Online Diabetes Community to Launch Global Diabetes Handprint Project
2. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
3. China-Biotics, Inc. Approved to List on the Nasdaq Global Market
4. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
5. Mentice Appoints Bjorn Larsson as Vice President of Global Marketing
6. International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive
7. The Plasmodium vivax genome provides new routes and challenges in the global fight against malaria
8. Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition
9. Kendle to Present at the UBS Global Life Sciences Conference
10. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
11. Boston Scientific to Participate in UBS Global Life Sciences Conference
Post Your Comments:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology:
(Date:5/12/2016)... 12, 2016 , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):